Dr Mary Kerr, CEO of KaNDy Therapeutics to present at the 4th Annual Investival Showcase, hosted by LSX and Jefferies

Dr Mary Kerr, CEO of KaNDy Therapeutics to present at the 25th Annual BIO-Europe Conference

Dr Mary Kerr, CEO of KaNDy Therapeutics to present at the 25th Annual BIO-Europe Conference During the BIO-Europe conference taking place from 11-13 November in Hamburg, Dr Mary Kerr will be [...]

Dr Mary Kerr, CEO of KaNDy Therapeutics to present at the SVB Leerink New Treatments Focused on Women’s Health Conference, New York

Dr Mary Kerr, CEO of KaNDy Therapeutics to present at the SVB Leerink New Treatments Focused on Women’s Health Conference, New York On the 10 October, Dr Mary Kerr will be attending and [...]

Dr Mary Kerr, CEO of KaNDy Therapeutics to present at Women’s Health Innovation Summit, Boston

In December (3rd-4th, 2019) 150 leaders in women’s health will be coming together in Boston at the Women’s Health Innovation Summit to drive innovation at the convergence of technology and [...]

Dr Mary Kerr, CEO of KaNDy Therapeutics presents at the Women’s Health and Technology Innovation Forum at King’s College London, Strand Campus, London

KaNDy Therapeutics announces the appointment of Andrew Kay as Independent Chairman of the Board

Dr Mary Kerr CEO KaNDy Therapeutics presents at the Biotech Showcase, San Francisco

KaNDy Therapeutics announces initiation of Phase 2b trial of NT-814 for the treatment of troublesome post-menopausal symptoms

KaNDy Therapeutics presents new compelling data with lead candidate NT-814 at The North American Menopause Society 2018 Annual Meeting

~ Treatment with NT-814 resulted in immediate improvements in bothersome post-menopausal symptoms~ ~ Phase Ib/IIa data showed rapid and significant reductions in the frequency and severity of hot [...]

KaNDy Therapeutics successfully raises £25 million in a Series C financing. Funding to advance a breakthrough non-hormonal treatment for symptoms of the menopause, into a Phase 2b study in Q4 2018

Stevenage, UK, 29 August 2018 – KaNDy Therapeutics, a clinical-stage Women’s Health company, today announces it has successfully closed a Series C financing round, raising £25 million from new US [...]

page 1 of 2
Contact Us

Please fill out the form to get in touch with us.

Not readable? Change text. captcha txt